Print Digg


Biosyntrx Launches Avantrx

Friday, August 15, 2008

Eye care practices now have a simple, safe and effective formula to offer patients as they strive to address the vast amount of science that links excess weight to an increased risk of developing degenerative eye diseases, including macular degeneration, cataract, glaucoma and diabetic retinopathy.

Avantrx is a revolutionary portion-control hydrogel gastric bulking formula that reduced portion size intake up to 50% in a clinical study, with an average 4-week weight loss of 7.6 lbs. (see study results and safety data under Avantrx scientific rationale file on this web site page).

Avantrx is an ultra-pure, superabsorbent, polyacrylic hydrogel with the ability to absorb up to 1000 times its weight in water. In the stomach, the microbeads released from the professional strength 750 mg capsule are about the size of grains of sugar. They are activated with water to gently expand within a few minutes to the size of grains of rice, filling the stomach with a soft, slippery mass, the volume of a large apple. After a few hours, the slippery gel-like substance safely passes through the GI tract, and is eliminated naturally - without any known harmful side effects.
Professional strength Avantrx differs completely from other gastric-bulking formulas because their expansion ratios are typically much smaller than the totally bio-inert acrylic polymer used in Avantrx.  Other particles smaller than 0.5mm are released into the small bowel or are absorbed very quickly, which makes the satiety potential of other gastric-bulking products no more effective than a glass of water.
The key to the efficacy of Avantrx is that its microbead structure forms large particles (avg. 1.5mm), which are retained by the stomach for hours, thereby modulating the release of gastric hormones like Grehlin, which send messages to the brain that one is hungry, and enhancing an earlier release of gastric hormones like Leptin, which cause one to feel full sooner.

The microbeads are made from a hydrogel polymer specifically developed for use as a temporary pre-meal gastric bulking agent. Polyacrylic hydrogels have been generally recognized as safe for many years and have been used in a wide variety of applications approved by the FDA for ingestion.

The polymer is totally bio-inert, a water-swelling slippery gel-like version of the acrylic polymers used in intraocular lenses.

Always consult your doctor before starting a weight-loss or weight-management program.

Recommended dosage: Professional Strength Avantrx must always be taken with at least 8 oz of water. It works best when taken one to three hours before a meal. If you don’t achieve a sense of fullness when taking one Avantrx capsule, increase the dosage to two capsules with an additional 8 oz of water. Everyone is different, so Avantrx works slightly differently for each individual. A potent full-spectrum multiple is always recommended when on a reduced calorie diet. We recommend Biosyntrx Oculair, or Macula Complete.

Precautions: Do not take more than 2 Avantrx capsules before any meal or more than six capsules a day. Diabetics, pregnant and nursing mothers, children under 18, morbidly obese people, or those with any form of pre-existing gastrointestinal disease or medical condition should consult with their physician before use.

Overdosage: Do not induce vomiting. Call your physician immediately.

Avantrx is manufactured in a GMP facility to meet the same standards for purity required for pharmaceutical products. Avantrx is certified Kosher and BSE Free.

These statements have not been evaluated by the U.S. Food and Drug Administration.

This product is not intended to diagnose, treat, cure or prevent disease.
Ellen Troyer, MT MA
Biosyntrx Chief Research Officer
Voting Member, Council for Responsible Nutrition


The patent-pending hydrogel polymer in professional strength Avantrx (SWELL) was invented by Richard C, Davis, MD.  Dr. Davis was the founder of a number of companies familiar to the ophthalmic and other medical specialty markets. Two of Dr. Davis' companies have been publicly traded. They include OccuLogix and UroQuest.  The Biosyntrx founders, staff and scientific advisory board are delighted to be the company chosen to introduce this amazing technology to the ophthalmic and optometric community. 
Excess weight has been linked to cardiovascular disease, cancer, stroke and Type 2 diabetes, which is now an epidemic in the United States. Therefore, a sensible portion control plan has become a focus of though-leading physicians in every medical specialty.  Over 50 studies are listed in the references below that also link excess weight to degenerative eye disease, which makes weight a problem that will be addressed by thought leading eye care professionals.
      Contact Biosyntrx Corporate office at 800-688-6815 to place Avantrx orders.

Crestpoint Management, LTD instrument announcement:
Moorfields Utility Forceps 2-510-2


Clinical references available in the Biosyntrx office.